Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025)

Biofrontera's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 300200.0% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 560.35% YoY), while the FY2025 annual figure was $3.0 million, up 100033.33% from the prior year.
• Cash from Investing Activities was $3.0 million for Q4 2025 at Biofrontera, up from $1000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $3.0 million in Q4 2025 to a low of -$3.0 million in Q3 2022.
• Historically, Cash from Investing Activities has averaged -$103200.0 across 5 years, with a median of -$1000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities tumbled 303500.0% in 2022, then jumped 300200.0% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$9000.0 in 2021, then plunged by 23077.78% to -$2.1 million in 2022, then soared by 103.5% to $73000.0 in 2023, then sank by 101.37% to -$1000.0 in 2024, then surged by 300200.0% to $3.0 million in 2025.
• The last three Cash from Investing Activities figures came in at $3.0 million (Q4 2025), $1000.0 (Q3 2025), and -$1000.0 (Q2 2025), per Business Quant data.